Recall: Club 13 Kratom Maeng Da Red

On 2018-04-05, the FDA announced that Club 13 is conducting a recall on Kratom Maeng Da Red due to possible contamination with salmonella. The recalled products were sold under the brand name(s) Club 13 during an unspecified time period throughout the regions shown in the map below.

In recent months, there have been 10 drugs recalls due to potential contamination, including special reserve kratom blend, powdered kratom products and more. Additionally, there have been 17 drug and medical device recalls due to other health hazards as well as 94 food recalls.

Company Contact Information:

Name: Club 13
Phone: 1-877-922-5783

Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.

Detailed Recall Information

Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.

Product Description: Kratom Maeng Da Red

Brand Name(s): Club 13

Reason for Recall: Salmonella

Official Recall Date: 2018-04-05

Additional information provided by the FDA.gov:

Club 13 of St. Augustine, FL is recalling 15-gram, 30-gram, 90-gram, 150-gram, and 454-gram pouches, and all bulk orders of "Maeng Da Red" kratom powder; and 5-count, 25-count, 50-count, 100-count, 120-count capsule, and all bulk capsule orders of Maeng Da Red" kratom bottles; and 5-count, 20-count, 25-count, 40-count, 50-count capsule "Maeng Da Red XS" kratom bottles because they have the potential to be contaminated with Salmonella , an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis. Read More.

More information may be available at FDA.gov